STAT3m
Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming the FDA, and more
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
The bears might point out that Eli Lilly's shares still look too expensive: The company's trailing price-to-earnings (P/E) ...
Eli Lilly says 'Zepbound superior to Wegovy in head-to-head trial
Eli Lilly said Wednesday that its weight-loss medication Zepbound (tirzepatide) demonstrated superior efficacy over Novo ...
healthday34m
Zepbound Bests Wegovy for Weight Loss in New Trial
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in ...
This weight loss drug helped people shed more pounds than Wegovy, new trial results show
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...
The Pharma Letter47m
Zepbound bests Wegovy in head-to-head weight loss trial
The battle between the two front runners in the vast weight loss released top-line results from the SURMOUNT-5 Phase IIIb ...
Eli Lilly’s stock rises as Zepbound weight-loss drug achieves a key goal
Eli Lilly & Co. Inc.’s stock rose 1.5% early Wednesday, after the company said its Zepbound weight-loss drug was more ...